MedPath

Prevalence of multidrug resistant micro-organism carriage in patients undergoing an ERCP in four different countries

Recruiting
Conditions
Duodenoscope associated infections
10019654
10019815
Registration Number
NL-OMON50359
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
343
Inclusion Criteria

- The subject is planned to undergo an ERCP procedure, either through an
outpatient department or an inpatient department
- The subject is >= 18 years old
- The subject is capable to understand the information required to give
informed consent

Exclusion Criteria

- In case the inclusion criteria were not met

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The prevalence of MDRO's in patients undergoing ERCP in four different<br /><br>countries: Italy, the Netherlands, United States and India.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- To identify risk factors that predict MDRO carriage.<br /><br>- Prevalence of contamination of duodenoscopes in a Dutch tertiary care setting.<br /><br>- If the presence of MDRO in the rectal and nasal/throat E-swabs predicts the<br /><br>presence of MDRO in the duodenum.<br /><br>- What is the composition of the duodenal microbiome of patients undergoing an<br /><br>ERCP.<br /><br>- What is the composition of the rectal microbiome of patients undergoing an<br /><br>ERCP<br /><br>- What is the incidence of duodenoscope-associated colonization and infection<br /><br>in patients who have been treated with a colonized duodenoscope.</p><br>
© Copyright 2025. All Rights Reserved by MedPath